J&J, Goldman stocks cut Dow’s price by 68 points after earnings

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 97%

United States News News

United States United States Latest News,United States United States Headlines

Shares of Johnson & Johnson and Goldman Sachs Group Inc. were the biggest drags on the Dow Jones Industrial Average even as both companies reported...

Shares of Johnson & Johnson JNJ and Goldman Sachs Group Inc. GS were the biggest drags on the Dow Jones Industrial Average DJIA, even as both companies reported first-quarter profit that topped expectations. J&J’s stock fell $3.92, or 2.4%, as the drug maker recorded a large charge as it settled lawsuits stemming from its talc-containing powders. Goldman’s stock shed $6.37, or 1.9, after the banker and broker’s profit beat, but revenue fell short. The two stocks’ combined $10.

... Shares of Johnson & Johnson JNJ and Goldman Sachs Group Inc. GS were the biggest drags on the Dow Jones Industrial Average DJIA , even as both companies reported first-quarter profit that topped expectations. J&J’s stock fell $3.92, or 2.4%, as the drug maker recorded a large charge as it settled lawsuits stemming from its talc-containing powders. Goldman’s stock shed $6.37, or 1.9, after the banker and broker’s profit beat, but revenue fell short. The two stocks’ combined $10.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stocks making the biggest moves premarket: Johnson & Johnson, Goldman Sachs, Sunrun and moreShares of Goldman Sachs shed nearly 4% after missing revenue estimates in its first-quarter earnings released before Tuesday's opening bell. JnJ tanking…probably because Jim Cramer opened his mouth. Whatever stock he mentions, tanks📉📉📉.
Source: CNBC - 🏆 12. / 72 Read more »

Johnson & Johnson beats on earnings and revenue, raises full-year guidanceEARNINGS: J&J reported adjusted earnings and revenue that topped Wall Street’s expectations, and lifted its full-year forecast. CFO Joseph Wolk joins us to discuss. Nothing on Liability on talc? Texas 2 step shouldn’t be allowed So they should stop using shell game bankruptcy strategies to avoid their legal responsibilities to women their product harmed.
Source: CNBC - 🏆 12. / 72 Read more »